Cargando…
HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
Adverse birth outcomes are common in HIV-positive pregnant women receiving combination antiretroviral therapy (cART), especially when cART is initiated in early pregnancy. The mechanisms remain poorly understood. Using a mouse model we demonstrate that protease inhibitor based-cART exposure beginnin...
Autores principales: | Mohammadi, Hakimeh, Papp, Eszter, Cahill, Lindsay, Rennie, Monique, Banko, Nicole, Pinnaduwage, Lakmini, Lee, Janice, Kibschull, Mark, Dunk, Caroline, Sled, John G., Serghides, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919912/ https://www.ncbi.nlm.nih.gov/pubmed/29700323 http://dx.doi.org/10.1038/s41598-018-24680-w |
Ejemplares similares
-
HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction
por: Papp, Eszter, et al.
Publicado: (2015) -
Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta
por: Gilmore, Julian C., et al.
Publicado: (2021) -
Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial
por: Siou, Kaitlin, et al.
Publicado: (2017) -
P‐Glycoprotein (P‐gp)/ABCB1 plays a functional role in extravillous trophoblast (EVT) invasion and is decreased in the pre‐eclamptic placenta
por: Dunk, Caroline E., et al.
Publicado: (2018) -
ACE2, TMPRSS2, and L-SIGN Expression in Placentae From HIV-Positive Pregnancies Exposed to Antiretroviral Therapy—Implications for SARS-CoV-2 Placental Infection
por: Kala, Smriti, et al.
Publicado: (2021)